Cellular Immunotherapy Data Resource (CIDR) shares knowledge
New cellular therapies, such as CAR-T cells, bring extraordinary chances to help people with cancer. The CIDR collects data about the long-term safety and efficacy of these therapies. In turn, the CIDR will give unprecedented access to these data to a diverse group of clinicians, researchers, manufacturers, payers, regulators, and the public.
CIDR is part of a national initiative
The National Cancer Institute awarded CIBMTR a grant to operate the CIDR as part of the Cancer Moonshot℠ to accelerate cancer research, under the Immuno-Oncology Translational Network (IOTN). The Cancer Moonshot℠ helps scientists in different organizations nationwide to join and quickly develop new immune therapies to prevent or cure cancer.
Cellular Therapy Registry is already active
Since 2016, CIBMTR has operated the Cellular Therapy Registry, which collects data on cellular immunotherapies for cancer. Parallel to CIBMTR’s data infrastructure for hematopoietic cell transplantation (HCT), used mostly to treat blood cancers, the CIDR gathers data on other cellular therapies for all cancers, including solid tumors.
The Cellular Therapy Registry collects essential data on the baseline characteristics of patients, along with pre- and post-infusion data, infusion details, disease response, and outcomes. The data are analyzed and may be used to plan pre-clinical studies and clinical trials.
CIDR Executive Committee
The CIDR Executive Committee is a standalone committee that interacts with the CIBMTR Advisory Committee regarding Working Committee activities. It oversees data collection forms, collaboration with treatment centers, the Cellular Immunotherapy for Cancer Working Committee, and the IOTN.
Cellular Immunotherapy for Cancer Working Committee (CICWC)
The Cellular Immunotherapy for Cancer Working Committee oversees studies related to cellular immunotherapies.
CIDR Stakeholders' Council
The CIDR Stakeholders' Council is comprised of members from the CIDR Executive Committee and representatives from professional societies, industry, payors, and patient advocacy groups. The Council has the opportunity to broaden the CIDR’s footprint in the cellular therapy field and serves as a forum to address issues common to all stakeholders. The Council advises the CIDR Executive Committee on initiatives and projects to maximize the utilization of this resource by the public at large.
CIDR excels through our partners
CIBMTR’s extensive expertise and established network of partnerships with physicians and data managers at participating centers create synergy. There is strength in numbers. We are unified in our mission to improve access and outcomes for patients worldwide who receive cellular therapy.
Congruent with CIBMTR practices, the CIDR grant enables us to:
- Develop data reporting strategies
- Manage the Cellular Therapy Registry
- Explore alternative approaches to capture and share data
- Optimize sharing of de-identified data with stakeholders and the public
Related Links: